Benzo[7]annulene-based GluN2B selective NMDA receptor antagonists: Surprising effect of a nitro group in 2-position

被引:16
作者
Gawaskar, Sandeep [1 ,2 ,3 ]
Schepmann, Dirk [1 ]
Bonifazi, Alessandro [4 ]
Robaa, Dina [5 ]
Sippl, Wolfgang [5 ]
Wuensch, Bernhard [1 ,3 ]
机构
[1] Univ Munster, Inst Pharmazeut & Med Chem, D-48149 Munster, Germany
[2] NRW Grad Sch Chem, D-48149 Munster, Germany
[3] Univ Munster, Cells In Mot Cluster Excellence EXC CiM 1003, D-48149 Munster, Germany
[4] Univ Camerino, Scuola Sci Farmaco & Prod Salute, I-62032 Camerino, Italy
[5] Univ Halle Wittenberg, Inst Pharmazeut & Med Chem, D-06120 Halle, Saale, Germany
关键词
NMDA receptor; GluN2B antagonists; 2-Nitrobenzo[7]annulen-7-amines; Structure affinity relationships; Selectivity; Conformational restriction; Docking studies; D-ASPARTATE RECEPTOR; IN-VITRO; PHARMACOLOGICAL EVALUATION; SUBUNIT ARRANGEMENT; ALZHEIMERS-DISEASE; NR2B SUBUNIT; IFENPRODIL; AFFINITY; LIGANDS; POTENT;
D O I
10.1016/j.bmcl.2015.10.076
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Benzo[7]annulen-7-amines 7 without further polar substituents have been reported as conformationally restricted Ro 25-6981 analogs and show unexpectedly high GluN2B affinity. Herein the corresponding 2-NO2 derivatives 8 were synthesized and pharmacologically evaluated. NO2 derivatives 8 show 5- to 10-fold higher GluN2B affinity than the unsubstituted ligands 7. Docking studies of ligands 7c and 8c reveal an important contribution of the 2-NO2-substituent in determining the binding pose and modulating the GluN2B affinity. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5748 / 5751
页数:4
相关论文
共 32 条
[1]   Synthesis and SAR studies of chiral non-racemic dexoxadrol analogues as uncompetitive NMDA receptor antagonists [J].
Banerjee, Ashutosh ;
Schepmann, Dirk ;
Koehler, Jens ;
Wuerthwein, Ernst-Ulrich ;
Wuensch, Bernhard .
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (22) :7855-7867
[2]   GluN2B-Selective N-Methyl-d-aspartate ( NMDA) Receptor Antagonists Derived from 3-Benzazepines: Synthesis and Pharmacological Evaluation of Benzo[7] annulen-7-amines [J].
Benner, Andre ;
Bonifazi, Alessandro ;
Shirataki, Chikako ;
Temme, Louisa ;
Schepmann, Dirk ;
Quaglia, Wilma ;
Shoji, Osami ;
Watanabe, Yoshihito ;
Daniliuc, Constantin ;
Wuensch, Bernhard .
CHEMMEDCHEM, 2014, 9 (04) :741-751
[3]   Ligands for glutamate receptors:: Design and therapeutic prospects [J].
Bräuner-Osborne, H ;
Egebjerg, J ;
Nielsen, EO ;
Madsen, U ;
Krogsgaard-Larsen, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (14) :2609-2645
[4]   (1S,2S)-1-(4-HYDROXYPHENYL)-2-(4-HYDROXY-4-PHENYLPIPERIDINO)-1-PROPANOL - A POTENT NEW NEUROPROTECTANT WHICH BLOCKS N-METHYL-D-ASPARTATE RESPONSES [J].
CHENARD, BL ;
BORDNER, J ;
BUTLER, TW ;
CHAMBERS, LK ;
COLLINS, MA ;
DECOSTA, DL ;
DUCAT, MF ;
DUMONT, ML ;
FOX, CB ;
MENA, EE ;
MENNITI, FS ;
NIELSEN, J ;
PAGNOZZI, MJ ;
RICHTER, KEG ;
RONAU, RT ;
SHALABY, IA ;
STEMPLE, JZ ;
WHITE, WF .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (16) :3138-3145
[5]   SEPARATION OF ALPHA-1 ADRENERGIC AND N-METHYL-D-ASPARTATE ANTAGONIST ACTIVITY IN A SERIES OF IFENPRODIL COMPOUNDS [J].
CHENARD, BL ;
SHALABY, IA ;
KOE, BK ;
RONAU, RT ;
BUTLER, TW ;
PROCHNIAK, MA ;
SCHMIDT, AW ;
FOX, CB .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (10) :3085-3090
[6]   NMDA receptor subunits: diversity, development and disease [J].
Cull-Candy, S ;
Brickley, S ;
Farrant, M .
CURRENT OPINION IN NEUROBIOLOGY, 2001, 11 (03) :327-335
[7]   Effect of CP101,606, a novel NR2B subunit antagonist of the N-methyl-D-aspartate receptor, on the volume of ischemic brain damage and cytotoxic brain edema after middle cerebral artery occlusion in the feline brain [J].
Di, X ;
Bullock, R ;
Watson, J ;
Fatouros, P ;
Chenard, B ;
White, F ;
Corwin, F .
STROKE, 1997, 28 (11) :2244-2251
[8]   Amyloid β, Glutamate, Excitotoxicity in Alzheimer's Disease: Are We on the Right Track? [J].
Esposito, Zaira ;
Belli, Lorena ;
Toniolo, Sofia ;
Sancesario, Giuseppe ;
Bianconi, Claudio ;
Martorana, Alessandro .
CNS NEUROSCIENCE & THERAPEUTICS, 2013, 19 (08) :549-555
[9]   Metabolism studies of ifenprodil, a potent GluN2B receptor antagonist [J].
Falck, Evamaria ;
Begrow, Frank ;
Verspohl, Eugen ;
Wuensch, Bernhard .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2014, 88 :96-105
[10]  
Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285